KLI

검색

Ulsan Univ. Repository Journal Papers Medicine

Medicine (의예과)3,519

browse: 제목 저자 키워드 발행일

1 Article Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study 이대호 ; Aaron S Mansfield ; Benjamin Besse ; et al 2021
2 Article Phase I Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-positive EGFR-mutant Non-small Cell Lung Cancer 이대호 ; Bo H Chao ; David Planchard ; et al 2021
3 Article Olmutinib in T790M-positive non-small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 study 강지형 ; 김동완 ; 김현진 ; et al 2021
4 Article Update of early phase clinical trials in cancer immunotherapy 이대호 2021
5 Article Lenvatinib versus sorafenib in first-line treatment of unresectable hepatocellular carcinoma: An inverse probability of treatment weighting analysis 김형돈 ; 방영학 ; 유창훈 ; et al 2021
6 Article Identification of Regorafenib Prognostic Index (REP Index) via Recursive Partitioning Analysis in Patients with Advanced Hepatocellular Carcinoma Receiving Systemic Treatment: A Real-World Multi-Institutional Experience 김형돈 ; 류백렬 ; 방영학 ; et al 2021
7 Article Evolving Treatment of Advanced Hepatocellular Carcinoma in the Asia-Pacific Region: A Review and Multidisciplinary Expert Opinion 유창훈 ; Bruce Wang ; Dee Lee ; et al 2021
8 Article Short versus prolonged courses of antimicrobial therapy for patients with uncomplicated Pseudomonas aeruginosa bloodstream infection: a retrospective study 배문숙 ; 정윤서 ; 배성만 ; et al 2021
9 Article Prospective multicentre randomised clinical trial comparing survival rates, quality of life and nutritional status between advanced gastric cancer patients with different follow-up intensities: study protocol for the STOFOLUP trial 구동회 ; 권오경 ; 김수미 ; et al 2021
10 Article Expression of the immune checkpoint molecule V-set immunoglobulin domain-containing 4 is associated with poor prognosis in patients with advanced gastric cancer 김소운 ; 노진 ; 박영수 ; et al 2021
11 Article Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100 유민희 ; Alina S Muntean ; Antonio Cubillo Gracian ; et al 2021
12 Article Treatment Outcomes and Safety of Mobocertinib in Platinum-Pretreated Patients With EGFR Exon 20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer: A Phase 1/2 Open-label Nonrandomized Clinical Trial 김상위 ; Caicun Zhou ; Celina Griffin ; et al 2021
13 Article A plain language summary of results from the ADAURA study: osimertinib after surgery for patients who have early-stage EGFR-mutated non-small cell lung cancer 김상위 ; Ajlan Atasoy ; Charuwan Akewanlop ; et al 2021
14 Article First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial 김상위 ; Adam Pluzanski ; Alain Vergnenegre ; et al 2021
15 Article The NHance ® Mutation-Equipped Anti-MET Antibody ARGX-111 Displays Increased Tissue Penetration and Anti-Tumor Activity in Advanced Cancer Patients 김상위 ; Ahmad Awada ; Alain Thibault ; et al 2021
16 Article Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study 김상위 ; Amy Roshak ; Byoung Chul Cho ; et al 2021
17 Article Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC 김상위 ; Ajlan Atasoy ; Charuwan Akewanlop ; et al 2021
18 Article Recurrence-associated gene signature in patients with stage I non-small-cell lung cancer 김권일 ; 김상위 ; 윤신교 ; et al 2021
19 Article Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical Trial 김성배 ; Antonino Musolino ; Bella Kaufman ; et al 2021
20 Article Talazoparib Versus Chemotherapy in Patients with HER2-negative Advanced Breast Cancer and a Germline BRCA1/2 Mutation Enrolled in Asian Countries: Exploratory Subgroup Analysis of the Phase III EMBRACA Trial. 김성배 ; Annabel Goodwin ; Joohyuk Sohn ; et al 2021

<< < 101 102 103 104 105 106 107 108 109 110 > >>

Recent Submissions

OAK Ulsan Univ. Repository는 국립중앙도서관 OAK Repository 보급사업으로 구축되었습니다.